A decision tree analysis to predict massive pulmonary hemorrhage in extremely low birth weight infants: a nationwide large cohort database

利用决策树分析预测极低出生体重儿发生大面积肺出血:一项全国性大型队列数据库研究

阅读:1

Abstract

OBJECTIVE: To develop a decision tree model using clinical risk factors to predict massive pulmonary hemorrhage (MPH) and MPH-related mortality in extremely low birth weight infants (ELBWIs). METHOD: We retrospectively analyzed data from a national multicenter prospective web-based registry using machine learning algorithms with the C5.0 decision tree model to develop a clinical prediction rule for MPH and MPH-related mortality in ELBWIs admitted to participating neonatal intensive care units (NICUs) from January 2013 to December 2020. This C5.0 model was developed through data preprocessing, attribute selection based on splitting criteria, and pruning techniques to minimize overfitting. RESULTS: A total of 5,752 infants were included. Of them, MPH occurred in 664 (11.5%) infants. Among infants with MPH, 136 (20.5%) infants died due to MPH. The decision tree model for MPH identified "gestational age (GA) ≤ 25(+2)" as the first discriminator, followed by "APGAR score at 5 min ≤ 7" and "multiple gestation". The decision tree model for MPH-related mortality identified "GA ≤ 25(+2)" as the first discriminator, followed by "APGAR score at 5 min ≤2". The predictive accuracy of the C5.0 MPH model achieved an area under the ROC curve (AUC) of 88.2% on the training set and 89.0% on the test set, while the MPH-related mortality model attained an AUC of 97.7% on the training set and an AUC of 97.4% on the test set. CONCLUSIONS: We developed a C5.0 decision tree model using clinical risk factors to predict MPH and MPH-related mortality in ELBWIs, enabling early identification of high-risk infants and facilitating timely interventions to improve neonatal outcomes. This decision-based risk stratification tool requires additional verification using larger multicenter cohorts to evaluate its practical applicability and clinical effectiveness before routine clinical implementation in NICUs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。